Cargando…
Prevalence of antiretroviral therapy treatment failure among HIV-infected pregnant women at first antenatal care: PMTCT Option B+ in Malawi
BACKGROUND: In Malawi’s PMTCT Option B+ program, HIV-infected pregnant women who are already receiving ART are continued on their current therapy regimen without testing for treatment failure at the first antenatal care (ANC) visit. HIV RNA screening at ANC may identify women with treatment failure...
Autores principales: | Chagomerana, Maganizo B., Miller, William C., Tang, Jennifer H., Hoffman, Irving F., Harrington, Bryna J., DiPrete, Bethany, Wallie, Shaphil, Jumbe, Allan, Limarzi, Laura, Hosseinipour, Mina C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6292583/ https://www.ncbi.nlm.nih.gov/pubmed/30543685 http://dx.doi.org/10.1371/journal.pone.0209052 |
Ejemplares similares
-
Three-year outcomes for women newly initiated on lifelong antiretroviral therapy during pregnancy – Malawi option B+
por: Chagomerana, Maganizo B., et al.
Publicado: (2023) -
Factors associated with a history of treatment interruption among pregnant women living with HIV in Malawi: A cross-sectional study
por: Sasse, Simone A., et al.
Publicado: (2022) -
Implementation and Operational Research: The Impact of Option B+ on the Antenatal PMTCT Cascade in Lilongwe, Malawi
por: Kim, Maria H., et al.
Publicado: (2015) -
Optimizing prevention of HIV mother to child transmission: Duration of antiretroviral therapy and viral suppression at delivery among pregnant Malawian women
por: Chagomerana, Maganizo B., et al.
Publicado: (2018) -
Brief Report: Impact of Option B+ on the Infant PMTCT Cascade in Lilongwe, Malawi
por: Kim, Maria H., et al.
Publicado: (2015)